| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |